Serial Number | 79118333 |
Word Mark | CBC COMPREHENSIVE BIOMARKER CENTER |
Filing Date | Monday, April 16, 2012 |
Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
Status Date | Saturday, April 16, 2022 |
Registration Number | 4486693 |
Registration Date | Tuesday, February 25, 2014 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, December 10, 2013 |
Description of Mark | The mark consists of the letters "cbc" at the top of the mark with the first "c" being black, the "b", from left to right, being mostly black with two diagonal white stripes and then the remainder light green, the second "c" is light green turning green at the bottom; six green dots are in a vertical stack below the first "c" and to their right in black is the wording "Comprehensive Biomarker Center". |
Indication of Colors claimed | The color(s) black, white, green and light green is/are claimed as a feature of the mark. |
Goods and Services | professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector featuring chemical and biochemical reagents for genetic analysis and testing; market reports and studies |
Goods and Services | Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical and veterinary diagnostic services in preclinical and clinical settings; medical and clinical examinations |
Disclaimer with Predetermined Text | "COMPREHENSIVE BIOMARKER CENTER" |
Goods and Services | scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the field of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely, analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, February 26, 2021 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, February 26, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, February 26, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Comprehensive Biomarker Center GmbH |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | DE |
Party Name | Comprehensive Biomarker Center GmbH |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 98 - Unknown |
Address | DE |
Party Name | febit holding GmbH |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | DE |
Party Name | febit holding GmbH |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | DE |
Event Date | Event Description |
Sunday, November 13, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
Sunday, November 13, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
Saturday, February 5, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
Tuesday, January 11, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Tuesday, January 11, 2022 | INVALIDATION PROCESSED |
Tuesday, October 26, 2021 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
Friday, February 26, 2021 | CANCELLED SECTION 71 |
Thursday, June 9, 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, October 28, 2014 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
Thursday, October 23, 2014 | CORRECTION TRANSACTION RECEIVED FROM IB |
Friday, June 27, 2014 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Wednesday, June 11, 2014 | FINAL DISPOSITION NOTICE SENT TO IB |
Tuesday, June 10, 2014 | FINAL DISPOSITION PROCESSED |
Sunday, May 25, 2014 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, May 6, 2014 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
Thursday, April 24, 2014 | CORRECTION TRANSACTION RECEIVED FROM IB |
Tuesday, February 25, 2014 | REGISTERED-PRINCIPAL REGISTER |
Sunday, February 2, 2014 | NOTIFICATION PROCESSED BY IB |
Monday, December 23, 2013 | CHANGE OF OWNER RECEIVED FROM IB |
Tuesday, December 10, 2013 | PUBLISHED FOR OPPOSITION |
Wednesday, November 20, 2013 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, November 20, 2013 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, November 20, 2013 | NOTICE OF PUBLICATION |
Monday, November 4, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, October 25, 2013 | ASSIGNED TO LIE |
Thursday, October 10, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, September 21, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, September 20, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, September 20, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 26, 2013 | NON-FINAL ACTION MAILED |
Tuesday, March 26, 2013 | NON-FINAL ACTION WRITTEN |
Monday, March 4, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, March 4, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, March 4, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, November 15, 2012 | REFUSAL PROCESSED BY IB |
Monday, October 22, 2012 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, October 22, 2012 | REFUSAL PROCESSED BY MPU |
Saturday, October 20, 2012 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Friday, October 19, 2012 | NON-FINAL ACTION WRITTEN |
Friday, October 19, 2012 | APPLICATION FILING RECEIPT MAILED |
Monday, October 15, 2012 | ASSIGNED TO EXAMINER |
Monday, October 15, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, October 11, 2012 | SN ASSIGNED FOR SECT 66A APPL FROM IB |